1. Home
  2. MNKD vs CLMT Comparison

MNKD vs CLMT Comparison

Compare MNKD & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • CLMT
  • Stock Information
  • Founded
  • MNKD 1991
  • CLMT 1916
  • Country
  • MNKD United States
  • CLMT United States
  • Employees
  • MNKD N/A
  • CLMT N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • CLMT Oil & Gas Production
  • Sector
  • MNKD Health Care
  • CLMT Energy
  • Exchange
  • MNKD Nasdaq
  • CLMT Nasdaq
  • Market Cap
  • MNKD 1.7B
  • CLMT 1.6B
  • IPO Year
  • MNKD 2004
  • CLMT 2006
  • Fundamental
  • Price
  • MNKD $5.33
  • CLMT $19.93
  • Analyst Decision
  • MNKD Strong Buy
  • CLMT Strong Buy
  • Analyst Count
  • MNKD 5
  • CLMT 6
  • Target Price
  • MNKD $10.80
  • CLMT $21.38
  • AVG Volume (30 Days)
  • MNKD 4.4M
  • CLMT 658.5K
  • Earning Date
  • MNKD 11-05-2025
  • CLMT 11-07-2025
  • Dividend Yield
  • MNKD N/A
  • CLMT N/A
  • EPS Growth
  • MNKD 149.32
  • CLMT N/A
  • EPS
  • MNKD 0.11
  • CLMT N/A
  • Revenue
  • MNKD $301,736,000.00
  • CLMT $4,070,400,000.00
  • Revenue This Year
  • MNKD $14.78
  • CLMT $1.02
  • Revenue Next Year
  • MNKD $19.36
  • CLMT $3.05
  • P/E Ratio
  • MNKD $50.09
  • CLMT N/A
  • Revenue Growth
  • MNKD 21.48
  • CLMT N/A
  • 52 Week Low
  • MNKD $3.38
  • CLMT $7.68
  • 52 Week High
  • MNKD $7.63
  • CLMT $23.75
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 49.48
  • CLMT 63.69
  • Support Level
  • MNKD $5.28
  • CLMT $18.15
  • Resistance Level
  • MNKD $5.62
  • CLMT $20.58
  • Average True Range (ATR)
  • MNKD 0.24
  • CLMT 0.78
  • MACD
  • MNKD -0.02
  • CLMT 0.09
  • Stochastic Oscillator
  • MNKD 58.80
  • CLMT 79.43

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About CLMT Calumet Specialty Products Partners L.P. Common Units

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.

Share on Social Networks: